LivaNova (LIVN) Interest Coverage Ratio Growth (3y) (2019 - 2026)
Powered by 
Analysis
LivaNova (LIVN) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -20.77% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 3.44% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 18.67% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -66.71% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 43.57% |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 80.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.46% |
| Mar 31, 2026 | 213.11% |
| Dec 31, 2025 | 55.41% |
| Sep 30, 2025 | 35.30% |
| Jun 30, 2025 | 18.03% |
| Mar 31, 2025 | 37.92% |
| Dec 31, 2024 | -15.57% |
| Sep 30, 2024 | 15.76% |
| Jun 30, 2024 | 47.02% |
| Mar 31, 2024 | 69.37% |
| Dec 31, 2023 | 29.34% |
| Sep 30, 2023 | 37.12% |
| Jun 30, 2023 | 33.90% |
| Mar 31, 2023 | -13.31% |
| Dec 31, 2022 | 26.69% |
| Sep 30, 2022 | -57.83% |
| Jun 30, 2022 | 31.99% |
| Mar 31, 2022 | 28.00% |
| Dec 31, 2021 | 26.60% |
| Sep 30, 2021 | 38.58% |